skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine

Preferred term

zalcitabine  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C9H13N3O3

has_role

inchi

  • InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1

inchikey

  • WREGKURFCTUGRC-POYBYMJQSA-N

mass

  • 211.21780

monoisotopicmass

  • 211.09569

smiles

  • Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1

subset

  • 3_STAR

synonym EXACT

  • 2',3'-dideoxycytidine

synonym RELATED

  • 2',3'-Dideoxycytidine
  • 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
  • DDC
  • DDCYD
  • Dideoxycytidine
  • zalcitabine

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:10101

Download this concept:

RDF/XML TURTLE JSON-LD